Detalhe da pesquisa
1.
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity.
Nat Immunol
; 24(2): 267-279, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36543958
2.
Ketolysis drives CD8+ T cell effector function through effects on histone acetylation.
Immunity
; 56(9): 2021-2035.e8, 2023 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37516105
3.
PYGBacking on glycogen metabolism to fuel early memory T cell recall responses.
Mol Cell
; 82(16): 2918-2921, 2022 08 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35985300
4.
Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.
Nature
; 591(7851): 645-651, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33589820
5.
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.
Nature
; 591(7851): 652-658, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33588426
6.
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors.
J Immunother Cancer
; 11(3)2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36914208
7.
An oncolytic virus-delivered TGFß inhibitor overcomes the immunosuppressive tumor microenvironment.
J Exp Med
; 220(10)2023 10 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37552475
8.
Fighting in a wasteland: deleterious metabolites and antitumor immunity.
J Clin Invest
; 132(2)2022 01 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35040434
9.
Carbon source availability drives nutrient utilization in CD8+ T cells.
Cell Metab
; 34(9): 1298-1311.e6, 2022 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35981545
10.
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.
J Exp Med
; 215(4): 1091-1100, 2018 04 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29511066